TrueWealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
TrueWealth Advisors's GILD Position: Q2 2026 in Review
TrueWealth Advisors increased its Gilead Sciences (GILD) stake by 9.5% in Q2 2026, buying an estimated $85.5K and bringing the position to 7,468 shares worth $943K. The position accounts for 0.21% of the portfolio, ranked #96.
TrueWealth Advisors first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $950K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- TrueWealth Advisors held 7,468 shares of Gilead Sciences worth $943K as of Q2 2026.
- TrueWealth Advisors bought 649 Gilead Sciences shares in Q2 2026, an estimated $85.5K.
- Gilead Sciences made up 0.21% of TrueWealth Advisors's portfolio in Q2 2026, its #96 holding.
- TrueWealth Advisors first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
- TrueWealth Advisors's Gilead Sciences position peaked at $950K in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on TrueWealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.